The CHARM programme.
Mansour
Jeanette
J
Peltier
Marcel
M
Oprisiu
Roxana
R
Achard
Jean Michel
JM
Fournier
Albert
A
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D020521:Stroke / Q000517:prevention & control*; D013777:Tetrazoles / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C081643:candesartan